Related Experiment Video

Updated: Aug 12, 2026

Computer-Aided Three-Dimensional Visualization in the Treatment of Locally Advanced Thyroid Cancer
03:55

Computer-Aided Three-Dimensional Visualization in the Treatment of Locally Advanced Thyroid Cancer

Published on: June 9, 2023

[Thyroid carcinoma: genetics, diagnosis, clinical features, and surgical treatment]

Hiroshi Takami1, Yoshifumi Ikeda, Gengo Tajima

  • 1Department of Surgery, Teikyo University School of Medicine, Japan.

Nihon Geka Gakkai Zasshi
|July 4, 2002
PubMed

Insights

Genetic testing for RET mutations is crucial for identifying medullary thyroid carcinoma. Early screening and prophylactic thyroidectomy aid in managing this cancer by targeting key oncogenes.

Area of Science:

  • Genetics and Molecular Biology
  • Oncology
  • Endocrinology

Background:

  • Thyroid carcinoma development involves oncogenes and tumor-suppressor genes.
  • The RET oncogene is significantly implicated in medullary and papillary thyroid carcinoma (PTC).
  • Thyroid-stimulating hormone receptor (TSH-R) and Gs alpha are linked to toxic thyroid adenoma.

Purpose of the Study:

  • To review the role of specific genes, particularly RET, in thyroid carcinoma.
  • To highlight the clinical significance of genetic testing for RET mutations in thyroid cancer management.

Main Methods:

  • Review of scientific literature on gene involvement in thyroid carcinoma.
  • Analysis of the established roles of RET, TSH-R, Gs alpha, and ras oncogenes.
  • Focus on diagnostic and prognostic implications of genetic alterations.

Main Results:

  • RET oncogene is a key factor in medullary and papillary thyroid carcinoma.
  • Germline RET mutation testing is standard practice for medullary thyroid carcinoma.
  • RET rearrangements may serve as prognostic indicators in PTC.

Conclusions:

  • Germline screening for RET mutations is now a common practice for medullary thyroid carcinoma patients.
  • Understanding genetic underpinnings is vital for early detection and management of thyroid cancers.

More Related Videos

Transoral Endoscopic Thyroidectomy Vestibular Approach for Thyroid Lobectomy05:12

Transoral Endoscopic Thyroidectomy Vestibular Approach for Thyroid Lobectomy

Published on: May 12, 2023

Establishment and Characterization of Patient-Derived Xenograft Models of Anaplastic Thyroid Carcinoma and Head and Neck Squamous Cell Carcinoma06:08

Establishment and Characterization of Patient-Derived Xenograft Models of Anaplastic Thyroid Carcinoma and Head and Neck Squamous Cell Carcinoma

Published on: June 2, 2023

Related Concept Videos

Hyperthyroidism II: Pathophysiology01:27

Hyperthyroidism II: Pathophysiology

Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH receptors...
Graves' Disease I: Introduction01:28

Graves' Disease I: Introduction

Graves' disease is an autoimmune disorder that causes hyperthyroidism, or overactivity of the thyroid gland. It results from autoantibodies called thyroid-stimulating immunoglobulins (TSIs), which bind to thyroid-stimulating hormone (TSH) receptors, leading to overstimulation of hormone production and a hypermetabolic state.EtiologyAlthough considered idiopathic, Graves’ disease has well-established contributing factors. There is a strong genetic component, with increased prevalence in...